Find all School-related info fast with the new School-Specific MBA Forum

It is currently 20 Aug 2014, 01:32

Close

GMAT Club Daily Prep

Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.

Customized
for You

we will pick new questions that match your level based on your Timer History

Track
Your Progress

every week, we’ll send you an estimated GMAT score based on your performance

Practice
Pays

we will pick new questions that match your level based on your Timer History

Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.

Events & Promotions

Events & Promotions in June
Open Detailed Calendar

A director of the Rexx Pharmaceutical Company argued that

  Question banks Downloads My Bookmarks Reviews Important topics  
Author Message
TAGS:
1 KUDOS received
Retired Moderator
User avatar
Joined: 01 Oct 2009
Posts: 485
Location: Bangalore,India
WE 1: 4yrs in IT Industry
Followers: 21

Kudos [?]: 103 [1] , given: 325

A director of the Rexx Pharmaceutical Company argued that [#permalink] New post 23 May 2010, 07:05
1
This post received
KUDOS
00:00
A
B
C
D
E

Difficulty:

(N/A)

Question Stats:

47% (01:49) correct 53% (01:41) wrong based on 15 sessions
A director of the Rexx Pharmaceutical Company argued that the development costs for new vaccines that the health department has requested should be subsidized by the government, since the marketing of vaccines promised to be less profitable than the marketing of any other pharmaceutical product. In support of this claim the director argued that sales of vaccines are likely to be lower since each vaccine is administered to a patient only once, whereas medicines that combat diseases and chronic illnesses are administered many times to each patient.

Which one of the following, if true, most weakens the support offered by the company director for the claim concerning the marketing of vaccines?

(A) Vaccines are administered to many more people than are most other pharmaceutical products.
(B) Many of the diseases that vaccines are designed to prevent can be successfully treated by medicines.
(C) Pharmaceutical companies occasionally market products that are neither medicines nor vaccines.
(D) Pharmaceutical companies other than the Rexx Pharmaceutical Company produce vaccines.
(E) The cost of administering a vaccine is rarely borne by the pharmaceutical company that manufactures that vaccine
1 KUDOS received
Manager
Manager
avatar
Joined: 16 Mar 2010
Posts: 120
Location: Halifax, Canada
Schools: Dalhousie School of Business (Corporate Residency MBA)
Followers: 5

Kudos [?]: 35 [1] , given: 8

Re: Rexx Pharmaceutical Company [#permalink] New post 23 May 2010, 07:13
1
This post received
KUDOS
I like A:
RaviChandra wrote:
A director of the Rexx Pharmaceutical Company argued that the development costs for new vaccines that the health department has requested should be subsidized by the government, since the marketing of vaccines promised to be less profitable than the marketing of any other pharmaceutical product. In support of this claim the director argued that sales of vaccines are likely to be lower since each vaccine is administered to a patient only once, whereas medicines that combat diseases and chronic illnesses are administered many times to each patient.

Which one of the following, if true, most weakens the support offered by the company director for the claim concerning the marketing of vaccines?

(A) Vaccines are administered to many more people than are most other pharmaceutical products.
This conflicts directly with the notion that that other products have multiple uses and are therefore more profitable.

(B) Many of the diseases that vaccines are designed to prevent can be successfully treated by medicines.
This suggests that people would be more inclined to forgo taking the vaccines (making them less profitable, thereby supporting the argument).

(C) Pharmaceutical companies occasionally market products that are neither medicines nor vaccines.
That's nice. We don't care.

(D) Pharmaceutical companies other than the Rexx Pharmaceutical Company produce vaccines.
Which means Rexx doesn't have a monopoly, which means their vaccines bear additional marketing costs and will have lower prices due to competitive pressure. Supports the argument.

(E) The cost of administering a vaccine is rarely borne by the pharmaceutical company that manufactures that vaccine
This has nothing to do with the number of vaccine doses administered.


_________________

I'm a current Corporate Residency MBA student at Dalhousie University (Nova Scotia, Canada).
This account is to help spread the word about this unique program, as well as to help provide a student perspective for MBA applications and GMAT experiences.

Every week I publish a blog about life in the CRMBA by interviewing current students. Find us on Twitter and Facebook, or post any questions/comments/concerns in this thread here on gmatclub.com

Highlights of the program include:

Specifically designed by Corporations/Employers, No work experience necessary, 8-month paid corporate residency, Grades/GMAT score not the main focus for admittance

Senior Manager
Senior Manager
avatar
Joined: 24 Jul 2009
Posts: 298
Followers: 2

Kudos [?]: 67 [0], given: 0

GMAT Tests User
Re: Rexx Pharmaceutical Company [#permalink] New post 23 May 2010, 07:44
RaviChandra wrote:
A director of the Rexx Pharmaceutical Company argued that the development costs for new vaccines that the health department has requested should be subsidized by the government, since the marketing of vaccines promised to be less profitable than the marketing of any other pharmaceutical product. In support of this claim the director argued that sales of vaccines are likely to be lower since each vaccine is administered to a patient only once, whereas medicines that combat diseases and chronic illnesses are administered many times to each patient.

Which one of the following, if true, most weakens the support offered by the company director for the claim concerning the marketing of vaccines?

(A) Vaccines are administered to many more people than are most other pharmaceutical products. >>> IMO, Correct >>> Though "each vaccine is administered to a patient only once", but if no. of subject are high...so low profits can be compensated for..
(B) Many of the diseases that vaccines are designed to prevent can be successfully treated by medicines.>>> Okie..but then what..Health department wants vaccines to be developed not medicines
(C) Pharmaceutical companies occasionally market products that are neither medicines nor vaccines.>>> IMO, Out of scope
(D) Pharmaceutical companies other than the Rexx Pharmaceutical Company produce vaccines. >>> It supports the manufactures claim in an indirect manner..as market size gets reduced..
(E) The cost of administering a vaccine is rarely borne by the pharmaceutical company that manufactures that vaccine >>> It's gud for the company and company should develop vaccines...But manufacture's claim is based on the "economy of scale".


OA plz.
Senior Manager
Senior Manager
avatar
Joined: 12 Apr 2010
Posts: 447
GMAT 1: Q V
Followers: 11

Kudos [?]: 78 [0], given: 157

GMAT Tests User
Re: Rexx Pharmaceutical Company [#permalink] New post 23 May 2010, 08:20
RaviChandra wrote:
A director of the Rexx Pharmaceutical Company argued that the development costs for new vaccines that the health department has requested should be subsidized by the government, since the marketing of vaccines promised to be less profitable than the marketing of any other pharmaceutical product. In support of this claim the director argued that sales of vaccines are likely to be lower since each vaccine is administered to a patient only once, whereas medicines that combat diseases and chronic illnesses are administered many times to each patient.

Which one of the following, if true, most weakens the support offered by the company director for the claim concerning the marketing of vaccines?

(A) Vaccines are administered to many more people than are most other pharmaceutical products.
(B) Many of the diseases that vaccines are designed to prevent can be successfully treated by medicines.
(C) Pharmaceutical companies occasionally market products that are neither medicines nor vaccines.
(D) Pharmaceutical companies other than the Rexx Pharmaceutical Company produce vaccines.
(E) The cost of administering a vaccine is rarely borne by the pharmaceutical company that manufactures that vaccine



The answer is A since it weakens the argument by stating that since vaccines are administered to a large population rather than medicines, the company will be able to cover a large portion of the population than ordinary medicines and therefore the point of vaccines sell 1 time, medicines are sold many times is weakened.
_________________

If you found the reply to be helpful, give kudos.

Retired Moderator
User avatar
Joined: 01 Oct 2009
Posts: 485
Location: Bangalore,India
WE 1: 4yrs in IT Industry
Followers: 21

Kudos [?]: 103 [0], given: 325

Re: Rexx Pharmaceutical Company [#permalink] New post 23 May 2010, 17:23
Its a Easy one OA:A
Director
Director
User avatar
Joined: 21 Dec 2010
Posts: 658
Followers: 10

Kudos [?]: 79 [0], given: 51

GMAT Tests User
Re: Rexx Pharmaceutical Company [#permalink] New post 07 May 2011, 04:42
yes it is like a sub 500 level question which 99/100 people get right on the exam
_________________

What is of supreme importance in war is to attack the enemy's strategy.

VP
VP
avatar
Status: There is always something new !!
Affiliations: PMI,QAI Global,eXampleCG
Joined: 08 May 2009
Posts: 1365
Followers: 11

Kudos [?]: 135 [0], given: 10

GMAT Tests User
Re: Rexx Pharmaceutical Company [#permalink] New post 11 May 2011, 01:15
A
_________________

Visit -- http://www.sustainable-sphere.com/
Promote Green Business,Sustainable Living and Green Earth !!

Re: Rexx Pharmaceutical Company   [#permalink] 11 May 2011, 01:15
    Similar topics Author Replies Last post
Similar
Topics:
The board of directors of Aqua Pharmaceuticals has requested eMJ 4 11 Aug 2013, 21:51
The pharmaceutical industry argues that because new drugs noboru 18 24 May 2010, 15:32
The Pharmaceutical industry argues that because new drugs beatgmat 6 29 Aug 2007, 19:01
The pharmaceutical industry argues that because new drugs Taku 10 21 Mar 2005, 00:37
Display posts from previous: Sort by

A director of the Rexx Pharmaceutical Company argued that

  Question banks Downloads My Bookmarks Reviews Important topics  


cron

GMAT Club MBA Forum Home| About| Privacy Policy| Terms and Conditions| GMAT Club Rules| Contact| Sitemap

Powered by phpBB © phpBB Group and phpBB SEO

Kindly note that the GMAT® test is a registered trademark of the Graduate Management Admission Council®, and this site has neither been reviewed nor endorsed by GMAC®.